1. Home
  2. CLW vs VNDA Comparison

CLW vs VNDA Comparison

Compare CLW & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

HOLD

Current Price

$17.90

Market Cap

293.0M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.23

Market Cap

289.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLW
VNDA
Founded
2005
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.0M
289.0M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
CLW
VNDA
Price
$17.90
$6.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$30.00
$14.00
AVG Volume (30 Days)
171.4K
1.3M
Earning Date
10-28-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
875.72
N/A
EPS
8.63
N/A
Revenue
$1,556,100,000.00
$212,074,000.00
Revenue This Year
$13.91
$12.01
Revenue Next Year
N/A
$21.57
P/E Ratio
$2.07
N/A
Revenue Growth
23.00
11.12
52 Week Low
$16.44
$3.81
52 Week High
$33.57
$6.88

Technical Indicators

Market Signals
Indicator
CLW
VNDA
Relative Strength Index (RSI) 48.18 63.55
Support Level $17.47 $4.89
Resistance Level $18.70 $6.88
Average True Range (ATR) 0.61 0.39
MACD 0.10 0.16
Stochastic Oscillator 65.93 70.10

Price Performance

Historical Comparison
CLW
VNDA

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: